Paget's disease of bone.
Nuclear medicine techniques are currently playing an important complementary role in the evaluation, management, and follow-up of the patient who is suspected of having Paget's disease of bone. The earlier diagnoses made possible by some of the described techniques should lead to a better understanding of the basic pathophysiology and, in addition, result in improved therapeutic modalities.
D000328:Adult; D000368:Aged; D000469:Alkaline Phosphatase / Q000097:blood; D000906:Antibodies / Q000032:analysis; D002116:Calcitonin / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use; D002132:Calcium Radioisotopes; D005260:Female; D006801:Humans; D006961:Hyperparathyroidism / Q000139:chemically induced / Q000175:diagnosis; D008297:Male; D008875:Middle Aged; D010001:Osteitis Deformans / Q000150:complications / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000276:immunology / Q000378:metabolism; D010710:Phosphates; D011859:Radiography; D011877:Radionuclide Imaging; D013326:Strontium Radioisotopes; D013667:Technetium; D014527:Uric Acid / Q000097:blood
D000906:Antibodies; D002132:Calcium Radioisotopes; D010710:Phosphates; D013326:Strontium Radioisotopes; D014527:Uric Acid; D013667:Technetium; D002116:Calcitonin; D000469:Alkaline Phosphatase